万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>药学

FRONTIERS IN PHARMACOLOGY《药理学前沿》 (官网投稿)

简介
  • 期刊简称FRONT PHARMACOL
  • 参考译名《药理学前沿》
  • 核心类别 SCIE(2024版), 外文期刊,
  • IF影响因子
  • 自引率
  • 主要研究方向医学-PHARMACOLOGY & PHARMACY 药学

主要研究方向:

等待设置主要研究方向
医学-PHARMACOLOGY & PHARMACY 药学

FRONTIERS IN PHARMACOLOGY《药理学前沿》(一年1卷). Frontiers in Pharmacology is a leading journal in its field, publishing rigorously peer-reviewed res...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿

2期刊网址:

https://www.frontiersin.org/journals/pharmacology

3投稿网址:

https://www.frontiersin.org/submission/SubmissionHome.aspx?domainId=1&fieldId=62&specialtyId=0&entityType=1&entityId=176

4、官网邮箱:

pharmacology.editorial.office@frontiersin.org

pharmacology@frontiersin.org

5、官网电话:+41(0)21 510 17 40

6、期刊刊期:一年出版1卷。

2021年8月20日星期

                                 

 

投稿须知【官网信息】

 

Scope & Mission

Frontiers in Pharmacology is a leading journal in its field, publishing rigorously peer-reviewed research across disciplines, including basic and clinical pharmacology, medicinal chemistry, pharmacy and toxicology. Field Chief Editor Heike Wulff at UC Davis is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.

Pharmacology is a medical science, as was recalled in the anniversary address for the 50th Spring Meeting in Mainz of the German Pharmacological Society in March 2009. This science, of the effect of medicinal bodies, gives us the handle to clarify the fundamental processes of life. It is also the science studying the interactions between chemicals and living beings directed to prevent, ameliorate or cure the deleterious consequences of their diseases, thereby providing medicine with weapons against diseases. Those major targets offer the opportunity to segment the field not only in studies considering pure basic topics but also by integrating basic and clinical science. This journal's editorial policy aims at identifying the most productive research projects through an evaluation by the scientific community and emphasizing proper use of translational science at both preclinical and clinical levels. Editors encourage collaboration between clinicians and basic scientists and welcome papers issued from a collaborative strategy between the academic and the private industrial sectors that could assist in the reversal of the current decline in the production of original medicines.

Frontiers in Pharmacology is a member of the Committee on Publication Ethics.

Submission

Frontiers in Pharmacology is composed of the following Specialty Sections:

Cardiovascular and Smooth Muscle Pharmacology

Drug Metabolism and Transport

Drugs Outcomes Research and Policies

ELSI in Science and Genetics

Ethnopharmacology

Experimental Pharmacology and Drug Discovery

Gastrointestinal and Hepatic Pharmacology

Inflammation Pharmacology

Integrative and Regenerative Pharmacology

Neuropharmacology

Obstetric and Pediatric Pharmacology

Pharmacoepidemiology

Pharmacogenetics and Pharmacogenomics

Pharmacology of Anti-Cancer Drugs

Pharmacology of Infectious Diseases

Pharmacology of Ion Channels and Channelopathies

Predictive Toxicology

Renal Pharmacology

Respiratory Pharmacology

Translational Pharmacology

The specialty sections of Frontiers in Pharmacology welcome submission of the following article types: Brief Research Report, Case Report, Clinical Trial, Community Case Study, Correction, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Study Protocol, Systematic Review, Technology and Code, Erratum, Policy and Practice Reviews, Curriculum, Instruction, and Pedagogy, Policy Brief and Protocols.

When submitting a manuscript to Frontiers in Pharmacology, authors must submit the material directly to one of the specialty sections. Manuscripts are peer-reviewed by the Associate and Review Editors of the respective specialty section.

……

更多详情:

https://www.frontiersin.org/journals/pharmacology#about


精彩点评摘录 查看所有点评明细
  • 2022/10/7 23:25:51
    体育是爱,生信是命对FRONTIERS IN PHARMACOLOGY《药理学前沿》的点评:
    期刊审稿较慢,但是文章质量不低
  • 2025/3/3 20:01:53
    啊泽到此一游对FRONTIERS IN PHARMACOLOGY《药理学前沿》的点评:
    11月投稿,3月录用,单体实验,任命编辑阶段特别长,编辑那个位置一直显示“Frontiers in Pharmacology Office”,把我整不会了,后面过了2个半月,就变成了一个人,后面就送外审了,送审还挺快的,1个月就2个审稿人意见回来,都是小修,小改一下就好了。返修后3天就接受了。总的来说,期刊总体速度还是可以的,但是不送审的话,你需要被卡在编辑任命阶段很久,起码得2个月。需要WB条带3次实验,可裁剪。反正静静等待就好了。
  • 2025/2/8 10:12:18
    中了,中了,我中了!对FRONTIERS IN PHARMACOLOGY《药理学前沿》的点评:
    Your manuscript is now in the initial validation stage, going through routine quality checks, and, if it meets essential research integrity and editorial criteria, it will then be sent out for peer review.
查看更多点评明细
  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭